Notice Information
Notice Title
Purchase of 177Lu- Dotatate (Lutathera (r)) to treat patients with neuroendocrine tumours
Notice Description
Purchase of 177Lu- Dotatate (Lutathera (r)) to treat patients with neuroendocrine tumours
Lot Information
Lot 1
The Royal Marsden Hospital NHS Foundation Trust needs to purchase 177Lu- Dotatate (Lutathera (r)) to treat patients with neuroendocrine tumours
Procurement Information
177Lu- Dotatate is used to treat patients with neuroendocrine tumours; currently this is the only licensed product on the market to treat this tumour and AAA is the sole distributor in the UK.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-028c9a
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/001348-2021
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £4,500,000 £1M-£10M
Notice Dates
- Publication Date
- 22 Jan 20215 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 22 Jan 20215 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Not Specified
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE ROYAL MARSDEN NHS FOUNDATION TRUST
- Contact Name
- tenders@chelwest.nhs.uk
- Contact Email
- tenders@chelwest.nhs.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- LONDON
- Postcode
- SW10 0XD
- Post Town
- South West London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI3 Inner London - West
- Small Region (ITL 3)
- TLI33 Kensington & Chelsea and Hammersmith & Fulham
- Delivery Location
- TLI London
-
- Local Authority
- Hammersmith and Fulham
- Electoral Ward
- Sands End
- Westminster Constituency
- Chelsea and Fulham
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-028c9a-2021-01-22T14:31:39Z",
"date": "2021-01-22T14:31:39Z",
"ocid": "ocds-h6vhtk-028c9a",
"initiationType": "tender",
"tender": {
"id": "DN521857",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Purchase of 177Lu- Dotatate (Lutathera (r)) to treat patients with neuroendocrine tumours",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods",
"description": "Purchase of 177Lu- Dotatate (Lutathera (r)) to treat patients with neuroendocrine tumours",
"lots": [
{
"id": "1",
"description": "The Royal Marsden Hospital NHS Foundation Trust needs to purchase 177Lu- Dotatate (Lutathera (r)) to treat patients with neuroendocrine tumours",
"hasOptions": false
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKI"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_OUTSIDE_SCOPE",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"procurementMethodRationale": "177Lu- Dotatate is used to treat patients with neuroendocrine tumours; currently this is the only licensed product on the market to treat this tumour and AAA is the sole distributor in the UK."
},
"awards": [
{
"id": "001348-2021-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-2921",
"name": "Advanced Accelerator Application"
}
]
}
],
"parties": [
{
"id": "GB-FTS-2920",
"name": "The Royal Marsden NHS Foundation Trust",
"identifier": {
"legalName": "The Royal Marsden NHS Foundation Trust"
},
"address": {
"streetAddress": "Unit G3, Harbour Yard, Chelsea Harbour",
"locality": "London",
"region": "UKI",
"postalCode": "SW10 0XD",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "tenders@chelwest.nhs.uk",
"email": "tenders@chelwest.nhs.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "http://www.royalmarsdent.nhs.uk",
"buyerProfile": "http://www.royalmarsdent.nhs.uk",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-2921",
"name": "Advanced Accelerator Application",
"identifier": {
"legalName": "Advanced Accelerator Application"
},
"address": {
"locality": "London",
"region": "UKI",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-525",
"name": "High Court",
"identifier": {
"legalName": "High Court"
},
"address": {
"locality": "London",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-2920",
"name": "The Royal Marsden NHS Foundation Trust"
},
"contracts": [
{
"id": "001348-2021-1",
"awardID": "001348-2021-1",
"status": "active",
"value": {
"amount": 4500000,
"currency": "GBP"
},
"dateSigned": "2021-01-22T00:00:00Z"
}
],
"language": "en"
}